About Eidos Therapeutics & BridgeBio Pharma

Eidos Therapeutics, an affiliate of BridgeBio Pharma, is a Phase 3 developmental-stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. We seek to treat this well-defined family of diseases at their collective source by stabilizing TTR. Our investigational product, acoramidis (AG10), is an orally administered small molecule designed to potently stabilize TTR, a potentially best-in-class treatment aiming to halt the progression of ATTR diseases.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. 

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe. 

To learn more about our story and company culture, visit us at eidostx.com/ | https://bridgebio.com

Who You Are

The Executive Director, Strategic Alliances role is a critical member in achieving the BridgeBio Cardiovascular team’s strategic objectives through external collaborations and with new and established partners. BridgeBio Cardiovascular is comprised at this time of the Eidos affiliate organization, the affiliate responsible for the development and commercialization of acoramidis for the treatment of ATTR-CM. As BridgeBio continues to grow, this role will play an active role in establishing new alliances under BrideBio Cardiovascular if and when they occur.

The ideal candidate for this role will interact with Eidos senior leadership and represent strategic business interests with existing and new collaborators. This specific position will:

1. Manage the Strategic Alliances function for Eidos Therapeutics, potentially including direct reports based on the number, scope and complexity of the alliances,
2. Lead the exciting large pharma partnership for EU as alliance manager and
3. Take over the Japan specific partnership as alliance manager after planned approval of the JNDA in 2025.

The Executive Director, Strategic Alliances will also be involved in standing up future alliances if and when they occur. This position will report directly to the Chief Business Office of BridgeBio Cardiovascular and sit on the Global Program Strategy, Business Development and Operations Leadership Team.

Responsibilities

Department head – Leading the BridgeBio Cardiovascular / Eidos Strategic Alliances function

• Unite the current alliance managers under one Strategic Alliances function, leading the team in setting the vision for a world class alliance management team
• Establish and maintain best practices for alliance governance and process, as well as relationship management with current and future partners
• Manage direct reports, responsible for (1) large operational vendor alliance and (2) single country alliance partner, respectively. (Note: As the team progresses through 2025 the alliance management responsibilities may be consolidated into one Executive Director role as workload shifts and more junior team members are reallocated to additional needs. Exact timing TBD based on approval timelines in Europe and Japan.)
• Ensure we efficiently manage our alliances, particularly when partnering with larger pharmaceutical companies. The nature of these partnerships will require the ability to influence and right-size external requests to protect the bandwidth of our smaller internal teams
• Participate as an active member of business development deal team as collaborations are structured, negotiated and executed

Alliance Manager for large pharma partnership – Managing the large pharma alliance as the team navigates the final steps in MAA approval, successfully transfers the MAH from BBIO to partner, and then transitions alliance focus from development/regulatory to enabling successful global commercialization

• Responsible for aligning commercial, medical affairs, regulatory, manufacturing and development activities for the large pharma alliance
• Lead strategic discussions pertaining to partnership matters and potential collaboration amendments
• Represent Eidos’s interests and provide a single point of communication for seeking / developing internal and external consensus to ensure collaboration objectives are met while maintaining a collaborative working relationship with all representatives and alliance committees
• Identify, address and resolve any issues related to collaboration activities
• Work closely with cross-functional groups (clinical, manufacturing, PV, legal, accounting, commercial, medical affairs) on collaboration matters, provide guidance regarding the letter and spirit of collaboration agreements to internal teams
• Coordinates Joint Steering Committee meetings between BridgeBio and large pharma partner, in collaboration with the partner’s alliance manager, with a strong focus on escalating the most critical business issue for discussion at JSC
• Support alliance sub-committee meetings (Joint Manufacturing Committee, Joint Development and Regulatory Committee, and Joint Commercialization Committee) to ensure appropriate topics are escalated and adjudicated at the appropriate forums, and clear communication regarding decisions and required actions are provided to all members of the alliance team

The above job description documents the general nature and level of work but is not intended to be an exhaustive list of activities, duties, and responsibilities required. Therefore, this role is expected to perform all other duties as assigned or required, as training and experience allow.

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements

Job Requirements:

• Advanced Graduate degree is preferred (PhD/MD/MBA/MS).
• Expertise or experience in established commercial or clinical stage partnerships.
• Commercialization and launch experience required, with extensive demonstrated experience collaborating closely with Medical Affairs teams
• Demonstrated business acumen and sophisticated understanding of all key areas of the drug development process: discovery, development, manufacturing and especially commercialization (given the registrational / commercial phase of our lead asset)
• Ability to appropriately manage alliance workload on internal teams, ensuring right sizing of external requests, and if appropriate, pushing back to protect the time of the internal organization.
• Experience managing multiple projects with the ability to deliver high-quality results in a fast-paced, time-sensitive environment
• Effective team player and excellent communicator with an ability to interact with senior-level stakeholders both inside and outside Eidos
• Hyperorganized with the ability to distill complex topics into clear and concise communications ex
• Ability to work independently within a dynamic, fast-paced entrepreneurial environment
• Ability to problem-solve and network with external stakeholders to identify solutions

Essential Requirements:

• Excellent oral and written communication skills required
• Excellent and demonstrated interpersonal skills: ability to understand and respond to multiple stakeholder perspectives and manage and handle conflict constructively required; Influence without direct authority will be critical
• Commercialization and launch experience required
• Able and willing to travel 10-20% of the time, including regular (3-4x per year) trips to BridgeBio’s offices in Zurich, Switzerland given the close collaboration required with BridgeBio Switzerland tea

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time 
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion